Identification, isolation, and synthesis of seven novel impurities of anti-diabetic drug Repaglinide.

about

Identification, isolation, and synthesis of seven novel impurities of anti-diabetic drug Repaglinide.

Item

http://www.wikidata.org/entity/Q48260378

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Identification, isolation, and ...... nti-diabetic drug Repaglinide.

@en

Identification, isolation, and ...... nti-diabetic drug Repaglinide.

@nl

type

Item

label

Identification, isolation, and ...... nti-diabetic drug Repaglinide.

@en

Identification, isolation, and ...... nti-diabetic drug Repaglinide.

@nl

prefLabel

Identification, isolation, and ...... nti-diabetic drug Repaglinide.

@en

Identification, isolation, and ...... nti-diabetic drug Repaglinide.

@nl

P1476

Identification, isolation, and ...... nti-diabetic drug Repaglinide.

@en

P2093

Mukkanti Khagga

http://www.w3.org/2001/XMLSchema#string

Pallavi Alegete

http://www.w3.org/2001/XMLSchema#string

Prasad Kancherla

http://www.w3.org/2001/XMLSchema#string

Srinivas Keesari

http://www.w3.org/2001/XMLSchema#string

P2860

Repaglinide, a new oral antidiabetic agent: a review of recent preclinical studies.

Repaglinide: a new short-acting insulinotropic agent for the treatment of type 2 diabetes.

Preclinical and clinical studies on safety and tolerability of repaglinide.

Repaglinide--a new compound for the treatment of patients with type 2 diabetes.

A review of clinical experience with the prandial glucose regulator, repaglinide, in the treatment of type 2 diabetes.

Defining the role of repaglinide in the management of type 2 diabetes mellitus: a review.

Recent trends in product development and regulatory issues on impurities in active pharmaceutical ingredient (API) and drug products. Part 2: Safety considerations of impurities in pharmaceutical products and surveying the impurity landscape.

Repaglinide: a review of its use in type 2 diabetes mellitus.

Recent trends in the impurity profile of pharmaceuticals.

Repaglinide in type 2 diabetes: a 24-week, fixed-dose efficacy and safety study.

P304

212-221

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/DTA.2207

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Parthasarathi Das

P577

2017-04-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28421713

http://www.w3.org/2001/XMLSchema#string